BAYLOR COLLEGE OF MEDICINE
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Electrical Stimulation for Critically Ill Post-Covid-19 Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT05198466
- Locations
- ๐บ๐ธ
Baylor College of Medicine, Houston, Texas, United States
Cost-effective Analysis of Two Approximation Devices in Closure of Gastrointestinal Defects
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 82
- Registration Number
- NCT05163665
- Locations
- ๐บ๐ธ
Baylor College of Medicine, Houston, Texas, United States
Pathfinder Registry
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 109
- Registration Number
- NCT05141032
- Locations
- ๐บ๐ธ
Baylor College of Medicine, Houston, Texas, United States
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT05134740
- Locations
- ๐บ๐ธ
Texas Children's Hospital, Houston, Texas, United States
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05132504
- Locations
- ๐บ๐ธ
Baylor College of Medicine, Houston, Texas, United States
๐บ๐ธBaylor St. Luke's Medical Center (BSLMC)., Houston, Texas, United States
๐บ๐ธHouston Methodist Hospital, Houston, Texas, United States
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 27
- Registration Number
- NCT05103631
- Locations
- ๐บ๐ธ
Houston Methodist Hospital, Houston, Texas, United States
Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 130
- Registration Number
- NCT05051189
- Locations
- ๐บ๐ธ
Texas childrens Hospital, Houston, Texas, United States
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-18
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 38
- Registration Number
- NCT05010564
- Locations
- ๐บ๐ธ
Texas Children's Hospital, Houston, Texas, United States
Alternate Day Versus Daily Oral Iron Therapy in Adolescents
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT05007899
- Locations
- ๐บ๐ธ
Texas Children's Pavilion for Women, Houston, Texas, United States
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT04995003
- Locations
- ๐บ๐ธ
Texas Children's Hospital, Houston, Texas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath